Clinical Trial Page
Clinical Trial Results:
An open-label trial of TMC125 in HIV-1 infected subjects who were randomized in any sponsor selected TMC125 trial to an active control arm and either virologically failed or completed the entire treatment period, or to placebo arm and were treated for at least 48 weeks.
| Summary | |
EudraCT number | 2004-001658-10 |
Trial protocol | GB BE IT PT ES |
Global completion date | 20 Mar 2007 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 06 Jul 2016 |
First version publication date | 13 Jun 2015 |
Other versions | |
Summary report(s) | 2004-001658-10_TMC125-C211 (CR006742)_CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.